Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank85
3Y CAGR+0.3%
5Y CAGR+24.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+0.3%/yr
vs +125.5%/yr prior
5Y CAGR
+24.4%/yr
Recent deceleration
Acceleration
-125.2pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$51.95M-18.5%
2024$63.72M+9.0%
2023$58.44M+13.5%
2022$51.49M+18.3%
2021$43.52M+150.1%
2020$17.40M+311.7%
2019$4.23M+112.4%
2018$1.99M+3.5%
2017$1.92M+1.9%
2016$1.89M-